A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to evaluate the clinical efficacy of bermekimab in participants with moderate to severe Hidradenitis Suppurativa (HS).
Epistemonikos ID: 8cb7f3953fe83f318e1654331f62962092759b61
First added on: May 09, 2024